Ownership history in WOLVERINE TRADING, LLC · 94 quarters on record
This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in TG THERAPEUTICS INC (TGTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | REDUCED | 100,200 | -166,000 | -62.4% | 0.00% | $3.7M | $35.99 |
| 2025 Q2 | ADDED | 266,200 | +260,080 | +4249.7% | 0.01% | $9.8M | $35.99 |
| 2025 Q1 | REDUCED | 6,120 | -92,780 | -93.8% | 0.00% | $244K | $39.43 |
| 2025 Q1 | REDUCED | 98,900 | -120,700 | -55.0% | 0.00% | $3.9M | $39.43 |
| 2025 Q1 | ADDED | 219,600 | +178,853 | +438.9% | 0.01% | $8.8M | $39.43 |
| 2024 Q4 | REDUCED | 40,747 | -59,053 | -59.2% | 0.00% | $1.3M | $30.10 |
| 2024 Q4 | REDUCED | 99,800 | -122,500 | -55.1% | 0.00% | $3.1M | $30.10 |
| 2024 Q4 | ADDED | 222,300 | +210,021 | +1710.4% | 0.01% | $7.0M | $30.10 |
| 2024 Q3 | REDUCED | 12,279 | -42,321 | -77.5% | 0.00% | $293K | $23.39 |
| 2024 Q3 | REDUCED | 54,600 | -112,700 | -67.4% | 0.00% | $1.3M | $23.39 |
As of 2025 Q4 — sorted by position size